Breast Cancer Research and Treatment
July 2016, Volume 158, Issue 1, pp 91–97
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overex
pressing metastatic breast cancer: overall survival and updated progression-fr
ee survival results from a phase II study
Email:[email protected]/*